CIGB-300 internalizes and impairs viability of NSCLC cells lacking actionable targets by inhibiting casein kinase-2 signaling
Ying Yi(Guangzhou First People's Hospital), Yasser Perera(Construction Development (Qatar))
Cited by 5
Related Papers
Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway
|Experimental and Therapeutic Medicine|2017|32